Search Results - "Lu, Lily D"
-
1
The Natural Stilbenoid (–)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants
Published in Antimicrobial agents and chemotherapy (17-11-2021)“…Antivirals are urgently needed to combat the global SARS-CoV-2/COVID-19 pandemic, supplement existing vaccine efforts, and target emerging SARS-CoV-2 variants…”
Get full text
Journal Article -
2
Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2
Published in The Journal of immunology (1950) (01-10-2011)“…Accumulating evidence suggests that autoreactive plasma cells play an important role in systemic lupus erythematosus (SLE). In addition, several…”
Get full text
Journal Article -
3
Therapeutic efficacy of CEP-33779, a novel selective JAK2 inhibitor, in a mouse model of colitis-induced colorectal cancer
Published in Molecular cancer therapeutics (01-04-2012)“…Constitutively activated STAT3 and STAT5 are expressed in a wide variety of human malignancies including solid and hematopoietic cancers and often correlate…”
Get full text
Journal Article -
4
A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis
Published in Arthritis research & therapy (21-04-2011)“…Janus kinase 2 (JAK2) is involved in the downstream activation of signal transducer and activator of transcription 3 (STAT3) and STAT5 and is responsible for…”
Get full text
Journal Article -
5
The In-Cell Western immunofluorescence assay to monitor PROTAC mediated protein degradation
Published in Methods in enzymology (01-01-2023)“…The In-Cell Western plate-based immunofluorescence assay is a useful methodology for monitoring protein levels and provides a facile moderate through-put…”
Get more information
Journal Article -
6
Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE
Published in International immunopharmacology (2012)“…Current therapies for late-stage systemic lupus erythematosus (SLE) are limited to cytotoxic agents. Delanzomib (CEP-18770) is an orally active, reversible P2…”
Get full text
Journal Article -
7
Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: Identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test
Published in Bioorganic & medicinal chemistry letters (01-02-2012)“…Serotoninergic neurotransmission has been implicated in modulation of learning and memory. It has been demonstrated that 5-hydroxytryptamine6 (5-HT6) receptor…”
Get full text
Journal Article -
8
Chemical-inducible, ecdysone receptor-based gene expression system for plants
Published in Transgenic research (01-02-2003)“…We have developed an inducible gene expression system with potential for field application using the ecdysone receptor (EcR) from the spruce budworm and the…”
Get full text
Journal Article -
9
Novel method of monitoring trace cytokines and activated STAT molecules in the paws of arthritic mice using multiplex bead technology
Published in BMC immunology (12-11-2010)“…The use of mouse models to study human disease provides useful data that can provide support for research projects or an existing drug discovery program. How…”
Get full text
Journal Article -
10
Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities
Published in Biochemical pharmacology (15-10-2009)“…Dimebolin (Dimebon), is a non-selective antihistamine approved in Russia for the treatment of allergy. Recently, this drug has been shown to be neuroprotective…”
Get full text
Journal Article -
11
Novel brain penetrant benzofuropiperidine 5-HT6 receptor antagonists
Published in Bioorganic & medicinal chemistry letters (01-01-2012)“…h5-HT6R Ki=4.4nM; h5-HT6R cAMP IC50=9.8nM; estimated rat % F=36; brain/plasma: 2. 7-Arylsulfonyl substituted benzofuropiperidine was discovered as a novel…”
Get full text
Journal Article -
12
Animal models of systemic lupus erythematosus (SLE) and ex vivo assay design for drug discovery
Published in Current protocols in pharmacology (01-06-2011)“…Systemic Lupus Erythematosus (SLE) is a debilitating and often fatal autoimmune disease that involves multiple organ systems. It can develop for years before…”
Get more information
Journal Article -
13
Dimebolin is a 5-HT sub(6) antagonist with acute cognition enhancing activities
Published in Biochemical pharmacology (15-10-2009)“…Dimebolin (Dimebon[TM]), is a non-selective antihistamine approved in Russia for the treatment of allergy. Recently, this drug has been shown to be…”
Get full text
Journal Article -
14
Dimebolin is a 5-HT 6 antagonist with acute cognition enhancing activities
Published in Biochemical pharmacology (2009)“…Dimebolin (Dimebon™), is a non-selective antihistamine approved in Russia for the treatment of allergy. Recently, this drug has been shown to be…”
Get full text
Journal Article